Assetmark Inc. Sells 8,544 Shares of Synopsys, Inc. $SNPS

Assetmark Inc. cut its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 64.4% in the first quarter, Holdings Channel.com reports. The firm owned 4,732 shares of the semiconductor company’s stock after selling 8,544 shares during the quarter. Assetmark Inc.’s holdings in Synopsys were worth $1,876,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. PeakShares LLC purchased a new stake in shares of Synopsys during the first quarter valued at $159,000. Angeles Wealth Management LLC grew its stake in Synopsys by 13.8% in the first quarter. Angeles Wealth Management LLC now owns 742 shares of the semiconductor company’s stock worth $294,000 after purchasing an additional 90 shares in the last quarter. Bessemer Group Inc. increased its holdings in Synopsys by 8.6% during the 1st quarter. Bessemer Group Inc. now owns 5,615 shares of the semiconductor company’s stock worth $2,226,000 after purchasing an additional 446 shares during the period. Jag Capital Management LLC purchased a new position in Synopsys during the 1st quarter worth $9,601,000. Finally, Independent Financial Group LLC bought a new stake in shares of Synopsys in the first quarter valued at about $303,000. 85.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Synopsys Stock Performance

Shares of SNPS stock opened at $373.47 on Friday. The company has a market capitalization of $71.51 billion, a P/E ratio of 86.45, a P/E/G ratio of 2.19 and a beta of 1.22. The business’s 50 day moving average is $456.13 and its two-hundred day moving average is $455.25. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the firm earned $3.67 EPS. The firm’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Wall Street Analyst Weigh In

SNPS has been the topic of several recent research reports. Stifel Nicolaus increased their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Needham & Company LLC reiterated a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Rosenblatt Securities lifted their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday, May 26th. Finally, Wells Fargo & Company upped their price target on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.